RxSight (RXST) Minority Interest (2020 - 2021)

RxSight's (RXST) quarterly Minority Interest came in at $353.3 million in Q2 2021, little changed on a QoQ basis from $353.3 million in Q4 2020.

RxSight (RXST) Minority Interest (2020 - 2021) Analysis & Trends

RxSight (RXST) has 2 years of Minority Interest data on file, last reported at $353.3 million in Q2 2021.

Quarterly Minority Interest changed N/A year-over-year to $353.3 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $353.3 million (changed N/A YoY) and the FY2020 annual result came in at $353.3 million, changed N/A from the prior year.
Minority Interest steadied at $353.3 million in Q2 2021, from $353.3 million in the prior quarter.
In the past five years, Minority Interest ranged from a high of $353.3 million in Q4 2020 to a low of $353.3 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	RxSight	259.94 Mn	-144.31 Mn	-

Download Data

Date	Value
Jun 30, 2021	353.30 Mn
Dec 31, 2020	353.30 Mn